abstract |
Disclosed are isolated human monoclonal antibodies that bind to and inhibit human CD20, and related antibody-based compositions and molecules. Further disclosed are pharmaceutical compositions containing the human antibodies, and therapeutic and diagnostic methods using the human antibodies. |